Long-term mortality in patients with end-stage renal disease undergoing hemodialysis and peritoneal dialysis: a propensity score matching retrospective study

Pengjie Zhang,Liru Xun,Nan Bao,Ding Tong,Bin Duan,Du Peng
DOI: https://doi.org/10.1080/0886022x.2024.2321320
IF: 3.222
2024-03-15
Renal Failure
Abstract:Background Hemodialysis (HD) and peritoneal dialysis (PD) are effective ways to treat end-stage renal disease (ERSD). This study aimed to investigate the differences in survival and the factors that influence it in patients with end-stage renal disease treated with HD or PD.
urology & nephrology
What problem does this paper attempt to address?
### Problems the Paper Attempts to Solve This paper aims to explore the differences in long-term survival rates of end-stage renal disease (ESRD) patients undergoing hemodialysis (HD) and peritoneal dialysis (PD) treatments, and to analyze the factors affecting the survival rates of these patients. Specifically, the research objectives include: 1. **Analyzing factors related to all-cause mortality in ESRD patients receiving renal replacement therapy**: Through a retrospective analysis, the researchers aim to understand which factors influence the survival rates of ESRD patients. 2. **Comparing long-term mortality rates of HD and PD treatment strategies in ESRD patients**: Using propensity score matching, the researchers attempt to evaluate the differences in long-term survival rates between the two dialysis methods. ### Research Background End-stage renal disease (ESRD) refers to the gradual decline of chronic kidney function caused by various reasons, leading to the accumulation of toxins and fluids in the body, causing significant damage to multiple systems. ESRD severely affects the quality of life and safety of patients. Hemodialysis (HD) and peritoneal dialysis (PD) are effective methods for treating ESRD, significantly improving patient survival rates. However, studies show that approximately 13.2% of maintenance dialysis patients die each year, especially those over 70 years old. Additionally, the 5-year survival rate is even below 40%. Different studies have shown inconsistent results regarding the survival rates of HD and PD patients. ### Research Methods - **Data Collection**: The study included ESRD patients who received HD or PD treatment at the center from January 1, 2008, to December 31, 2021. - **Propensity Score Matching**: To reduce the impact of baseline information imbalance on survival, the researchers applied propensity score matching, ultimately matching 922 patients (461 in each group). - **Statistical Analysis**: Kaplan-Meier survival curves and log-rank tests were used to compare the survival rates of the two groups, and multivariate regression analysis was conducted to determine independent predictors of survival. ### Main Results - **Short-term Survival Rates**: There were no significant differences in 1-year, 2-year, 3-year, and 4-year mortality rates between the HD and PD groups. - **Long-term Survival Rates**: The 5-year and 10-year mortality rates in the HD group were 15.8% and 17.6%, respectively, while in the PD group, they were 21.0% and 27.3%, respectively. The 5-year and 10-year mortality rates in the HD group were significantly lower than those in the PD group. - **Factors Affecting Survival Rates**: - **All-cause Mortality**: Age, weight, hypertension, serum creatinine, and comorbid tumors are independent factors affecting the survival rates of ESRD patients. - **HD Group**: Age, hypertension, PTH, serum creatinine, and peripheral vascular disease (PVD) are factors affecting survival rates. - **PD Group**: Age and weight are factors affecting survival rates. ### Conclusion The study found that the long-term mortality rate is higher in the PD group than in the HD group, suggesting that HD may be superior to PD. This conclusion helps clinicians choose the appropriate dialysis method, take effective preventive measures, and improve patient survival outcomes.